The Latest Breaking News from Vaccine

Pfizer (NYSE:PFE) announced positive top-line data from the Phase 3 clinical trial RENOIR investigating its bivalent RSV prefusion F vaccine candidate, RSVpreF, when administered to adults 60 years of age or older. Pfizer, Inc. shares traded in a range of $47.27 to $47.95 on day volume of 14.45 million shares, closed…

Anti-lockdown advocates have been claiming online this week that Victoria's Chief Health Officer Brett Sutton admitted that vaccines never worked. But that's not what he said.

Serbian tennis star, who also missed Australian Open this year, says he will keep in ‘good shape and positive spirit’.

Paris (AFP) - Hundreds of Europeans have crossed borders for the monkeypox vaccine, sparking calls to address a gaping inequality in access to doses between nations.

Djokovic had hoped for a change in the rules ahead of the tournament but will now miss his second grand slam of the season

The rollout in Ireland has previously been criticised for being too slow

Over 200 Lanarkshire residents have already been vaccinated

The number of monkeypox cases reported globally dropped by 21% in the last week, reversing a month-long trend of rising infections in a possible sign the outbreak may be starting to decline in Europe, according to an report issued by the World Health Organization on Thursday

Fainting and fatigue may signal onset of variant, experts say